Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5155)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients. World J Gastroenterol 2014; 20(32): 11340-11346 [PMID: 25170220 DOI: 10.3748/wjg.v20.i32.11340] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11340.htm |
| Number | Citing Articles |
| 1 |
Zsófia Brigitta Nagy, Barnabás Wichmann, Alexandra Kalmár, Orsolya Galamb, Barbara Kinga Barták, Sándor Spisák, Zsolt Tulassay, Béla Molnár. Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens. Clinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-016-0305-3
|
| 2 |
Guiming Chen, Jin Peng, Weiguo Zhu, Guangzhou Tao, Yaqi Song, Xilei Zhou, Wanwei Wang. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0263-6
|
| 3 |
Shihua Yao, Tiejun Zhao, Hai Jin. Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer. Biomedicine & Pharmacotherapy 2015; 70: 72 doi: 10.1016/j.biopha.2015.01.013
|
| 4 |
Huifen Li, Weihua Huang, Rongcheng Luo. RETRACTED ARTICLE: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0323-z
|
| 5 |
David Weber, Laurence Amar, Daniel Gödde, Christian Prinz. Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer. Oncotarget 2018; 9(43): 27256 doi: 10.18632/oncotarget.25535
|
| 6 |
Veronika Vymetalkova, Pavel Vodicka, Sona Vodenkova, Sergio Alonso, Regine Schneider-Stock. DNA methylation and chromatin modifiers in colorectal cancer. Molecular Aspects of Medicine 2019; 69: 73 doi: 10.1016/j.mam.2019.04.002
|
| 7 |
Igor Lopes dos Santos, Karlla Greick Batista Dias Penna, Megmar Aparecida dos Santos Carneiro, Larisse Silva Dalla Libera, Jéssica Enocencio Porto Ramos, Vera Aparecida Saddi. Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review. Molecular Biology Reports 2021; 48(2): 1853 doi: 10.1007/s11033-020-06075-1
|
| 8 |
Wei Zhu, Xiaoliang Ji. The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database. Pathology & Oncology Research 2020; 26(2): 771 doi: 10.1007/s12253-019-00619-y
|
| 9 |
Alpaslan Tanoglu, Ahmet Ziya Balta, Ufuk Berber, Yavuz Ozdemir, Levent Emirzeoglu, Abdurrahim Sayilir, Ilker Sucullu. microRNA Expression Profile in Patients with Stage II Colorectal Cancer: A Turkish Referral Center Study. Asian Pacific Journal of Cancer Prevention 2015; 16(5): 1851 doi: 10.7314/APJCP.2015.16.5.1851
|
| 10 |
Lina Cekaite, Peter W. Eide, Guro E. Lind, Rolf I. Skotheim, Ragnhild A. Lothe. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget 2016; 7(6): 6476 doi: 10.18632/oncotarget.6390
|
| 11 |
Yuzhou Wang, Jinmei Li, Hongming Chen, Yanli Mo, Haiyin Ye, Yiping Luo, Kangwen Guo, Zongjiong Mai, Ying Zhang, Baoying Chen, Yijin Zhou, Zhixiong Yang. Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer. Gene 2016; 591(2): 333 doi: 10.1016/j.gene.2016.06.001
|
| 12 |
Agnieszka Piechowska, Celina Kruszniewska-Rajs, Magdalena Kimsa-Dudek, Magdalena Kołomańska, Barbara Strzałka-Mrozik, Joanna Gola, Stanisław Głuszek. The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studies. Journal of Cancer Research and Clinical Oncology 2022; 148(7): 1569 doi: 10.1007/s00432-022-03977-4
|
| 13 |
Lu Sun, Zhixian Guo, Jihong Sun, Jingjing Li, Zihui Dong, Yize Zhang, Jianan Chen, Quancheng Kan, Zujiang Yu. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway. Biomedicine & Pharmacotherapy 2018; 107: 168 doi: 10.1016/j.biopha.2018.07.151
|
| 14 |
Daniele Fanale, Marta Castiglia, Viviana Bazan, Antonio Russo. Non-coding RNAs in Colorectal Cancer. Advances in Experimental Medicine and Biology 2016; 937: 207 doi: 10.1007/978-3-319-42059-2_11
|
| 15 |
Petra Vychytilova-Faltejskova, Ondrej Slaby. MicroRNA in Human Malignancies. 2022; : 203 doi: 10.1016/B978-0-12-822287-4.00007-4
|
| 16 |
Zi-Qing Yang, Chang-An Wu, Yi-Xing Cheng. Prognostic Value of microRNA-133a Expression and Its Clinicopathologic Significance in Non-Small Cell Lung Cancer: A Comprehensive Study Based on Meta-Analysis and the TCGA Database. Oncology Research and Treatment 2018; 41(12): 762 doi: 10.1159/000492343
|
| 17 |
Annunziata Di Domenico, Tabea Wiedmer, Ilaria Marinoni, Aurel Perren. Genetic and epigenetic drivers of neuroendocrine tumours (NET). Endocrine-Related Cancer 2017; 24(9): R315 doi: 10.1530/ERC-17-0012
|
| 18 |
Shanthi Sabarimurugan, Chellan Kumarasamy, Madhav Madurantakam Royam, Karthik Lakhotiya, Gothandam Kodiveri Muthukaliannan, Suja Ramalingam, Rama Jayaraj. Validation of miRNA prognostic significance in stage II colorectal cancer. Medicine 2019; 98(12): e14570 doi: 10.1097/MD.0000000000014570
|
| 19 |
Rina Das, Dinesh Kumar Mehta, Nidhi Gupta. Understanding the Potential of mRNA as Biomarker to Revolutionize
Diagnosis of Colorectal Cancer. Drug Research 2024; 74(03): 102 doi: 10.1055/a-2244-6572
|
| 20 |
Sabrina Caporali, Cosimo Calabrese, Marilena Minieri, Massimo Pieri, Umberto Tarantino, Mario Marini, Stefano D’Ottavio, Silvia Angeletti, Alessandro Mauriello, Claudio Cortese, Sergio Bernardini, Alessandro Terrinoni. The miR-133a, TPM4 and TAp63γ Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression. International Journal of Molecular Sciences 2021; 22(18): 9818 doi: 10.3390/ijms22189818
|